Novak D - Search Results

1

FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor.

Sun Q, Novak D, Hüser L, Poelchen J, Wu H, Granados K, Federico A, Liu K, Steinfass T, Vierthaler M, Umansky V, Utikal J. Sun Q, et al. Among authors: novak d. Int J Cancer. 2021 Aug 1;149(3):657-674. doi: 10.1002/ijc.33591. Epub 2021 May 6. Int J Cancer. 2021. PMID: 33837564

2

SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma.

Hüser L, Sachindra S, Granados K, Federico A, Larribère L, Novak D, Umansky V, Altevogt P, Utikal J. Hüser L, et al. Among authors: novak d. Int J Cancer. 2018 Dec 15;143(12):3131-3142. doi: 10.1002/ijc.31609. Epub 2018 Oct 16. Int J Cancer. 2018. PMID: 29905375

3

Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulation.

Wu H, Larribère L, Sun Q, Novak D, Sachindra S, Granados K, Umansky V, Utikal J. Wu H, et al. Among authors: novak d. Int J Cancer. 2018 Dec 1;143(11):2962-2972. doi: 10.1002/ijc.31799. Epub 2018 Sep 29. Int J Cancer. 2018. PMID: 30110134

4

Targeting SOX2 in anticancer therapy.

Hüser L, Novak D, Umansky V, Altevogt P, Utikal J. Hüser L, et al. Among authors: novak d. Expert Opin Ther Targets. 2018 Dec;22(12):983-991. doi: 10.1080/14728222.2018.1538359. Epub 2018 Oct 26. Expert Opin Ther Targets. 2018. PMID: 30366514 Review.

5

Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.

Orouji E, Federico A, Larribère L, Novak D, Lipka DB, Assenov Y, Sachindra S, Hüser L, Granados K, Gebhardt C, Plass C, Umansky V, Utikal J. Orouji E, et al. Among authors: novak d. Int J Cancer. 2019 Dec 15;145(12):3462-3477. doi: 10.1002/ijc.32432. Epub 2019 Jun 9. Int J Cancer. 2019. PMID: 31131878

6

SOX2 in development and cancer biology.

Novak D, Hüser L, Elton JJ, Umansky V, Altevogt P, Utikal J. Novak D, et al. Semin Cancer Biol. 2020 Dec;67(Pt 1):74-82. doi: 10.1016/j.semcancer.2019.08.007. Epub 2019 Aug 11. Semin Cancer Biol. 2020. PMID: 31412296 Free article. Review.

7

T-type calcium channel inhibition restores sensitivity to MAPK inhibitors in de-differentiated and adaptive melanoma cells.

Granados K, Hüser L, Federico A, Sachindra S, Wolff G, Hielscher T, Novak D, Madrigal-Gamboa V, Sun Q, Vierthaler M, Larribère L, Umansky V, Utikal J. Granados K, et al. Among authors: novak d. Br J Cancer. 2020 Mar;122(7):1023-1036. doi: 10.1038/s41416-020-0751-8. Epub 2020 Feb 17. Br J Cancer. 2020. PMID: 32063604 Free PMC article.

8

Cellular Reprogramming-A Model for Melanoma Cellular Plasticity.

Granados K, Poelchen J, Novak D, Utikal J. Granados K, et al. Among authors: novak d. Int J Mol Sci. 2020 Nov 5;21(21):8274. doi: 10.3390/ijms21218274. Int J Mol Sci. 2020. PMID: 33167306 Free PMC article. Review.

9

Melanoma Cellular Plasticity.

Novak D, Utikal J. Novak D, et al. Int J Mol Sci. 2022 Jun 8;23(12):6401. doi: 10.3390/ijms23126401. Int J Mol Sci. 2022. PMID: 35742846 Free PMC article.

10

Function and significance of MicroRNAs in benign and malignant human stem cells.

Utikal J, Abba M, Novak D, Moniuszko M, Allgayer H. Utikal J, et al. Among authors: novak d. Semin Cancer Biol. 2015 Dec;35:200-11. doi: 10.1016/j.semcancer.2015.07.001. Epub 2015 Jul 17. Semin Cancer Biol. 2015. PMID: 26192966 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

560 results

Search Page

Filters